SCHEMBL20901322

SCHEMBL20901322

CCCCC(CC)C(NC=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 2/20 0.43
POLB P06746 1/20 0.41
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TAAR1 Q96RJ0 1/20 0.38
CYP1A2 P05177 4/20 0.37
CYP3A4 P08684 4/20 0.37
CYP2C9 P11712 4/20 0.37
TSHR P16473 4/20 0.37
CYP2C19 P33261 4/20 0.37
ADH1B P00325 1/20 0.37
ADH1C P00326 1/20 0.37
ADH1A P07327 1/20 0.37
ADH4 P08319 1/20 0.37
ADH7 P40394 1/20 0.37
EPHX1 P07099 1/20 0.37
CYP2D6 P10635 2/20 0.36
CTSK P43235 4/20 0.36
CTSL P07711 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5225390 0.78 POLB (0.45) ALDH1A1KDM4EPOLBMEN1KMT2A
SCHEMBL8086502 0.73 ALDH1A1 (0.49) ALDH1A1KDM4EPOLBMEN1KMT2A
Diethylamine SCHEMBL11106466 0.73 ALDH1A1 (0.50) ALDH1A1KDM4EPOLBMEN1KMT2A
SCHEMBL27485625 0.73 POLB (0.41) ALDH1A1KDM4EPOLBMEN1KMT2A
SCHEMBL27680417 0.73 ALDH1A1 (0.40) ALDH1A1KDM4EPOLBMEN1KMT2A
SCHEMBL28051602 0.71 LTA4H (0.40) CYP2D6CTSKCTSLCTSB
SCHEMBL12789448 0.71 KMT2A (0.48) ALDH1A1POLBMEN1KMT2ATAAR1
SCHEMBL13122615 0.70 ALDH1A1 (0.50) ALDH1A1KDM4EPOLBCYP3A4CYP2D6
SCHEMBL5223938 0.70 MEN1 (0.44) ALDH1A1KDM4EPOLBMEN1KMT2A
Phosphonic Acid SCHEMBL9264939 0.70 ALDH1A1 (0.47) ALDH1A1KDM4EPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10259785-B2 Therapeutic compounds and compositions EXITHERA PHARMACEUTICALS, INC. (US) 2019-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10259785-B2 Therapeutic compounds and compositions KLK5, KLKB1, KLK2 ALDH1A1 4490/4885KDM4E 556/4885POLB 3897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.